Trial Profile
Effect of trastuzumab emtansine on splenic volume and bone marrow hyperplasia in patients with metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2017
Price :
$35
*
At a glance
- Drugs Trastuzumab emtansine (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Pharmacodynamics
- 20 Feb 2017 New trial record